Dror Ortho-Design advances U.S. commercialization with next-generation ZSmile Platform
Dror Ortho-Design secures FDA clearance for ZSmile. Explore what pneumatic aligners mean for orthodontic innovation and adoption.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Profusa Lumee Oxygen gains pre-approval orders as EU MDR decision looms
Profusa secures Lumee Oxygen orders ahead of EU MDR clearance. Discover what this means for CLTI monitoring and 2026 commercialization.
Pharma & Biotech
Starton Therapeutics advances STAR-LLD as delivery innovation in multiple myeloma
Starton Therapeutics advances STAR-LLD in Phase 2a. Explore how continuous lenalidomide delivery could reshape multiple myeloma care.
Medical Devices & Diagnostics
STAAR Surgical advances EVO ICL adoption as FDA approval reframes high-myopia treatment economics
FDA expands EVO ICL use to ages 21–60. Discover what this means for refractive surgery, safety data, and the shift away from laser vision correction.
Pharma & Biotech
What Avidity Biosciences Phase 1/2 MARINA results reveal about the future of DM1 drug development
NEJM publication of Avidity Biosciences delpacibart etedesiran data raises new questions for DM1 treatment. Discover what this changes next.
Pharma & Biotech
Gilead expands its HIV playbook as lenacapavir moves from niche drug to platform strategy
Gilead’s CROI 2026 data highlight lenacapavir’s evolution into a platform for HIV treatment and prevention. Explore what this changes for clinicians and regulators.
Pharma & Biotech
What Omeros Corporation’s OncotoX-AML study reveals about mutation-agnostic AML therapies
Omeros Corporation advances OncotoX-AML after primate data. Explore what this means for AML therapy, risks ahead, and why clinicians are watching closely.
Medical Devices & Diagnostics
What GE HealthCare’s $35m BARDA expansion reveals about the future of trauma imaging
GE HealthCare expands its BARDA-backed artificial intelligence ultrasound program. Discover what this changes for trauma care and emergency preparedness.
Medical Devices & Diagnostics
How UNC Health’s Mevion deployment reflects a reset in proton therapy economics
UNC Health selects Mevion’s compact proton system. Discover what this means for proton therapy economics, workflows, and academic cancer care.
Medical Devices & Diagnostics
Instanosis secures FDA breakthrough status for xylazine urine test as overdose care faces new diagnostic gaps
Instanosis wins FDA breakthrough status for its xylazine urine test. Find out why this matters for overdose diagnostics and what challenges remain.